Journal article
Systematic review and meta‐analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease
Abstract
BACKGROUND AND AIM: Vedolizumab is a novel monoclonal antibody used in patients with inflammatory bowel disease, often affecting women of child-bearing age. We aimed to compare maternal and fetal adverse outcomes in pregnancies of women with inflammatory bowel disease exposed to vedolizumab versus those on other treatment.
METHODS: We performed a systematic literature search through December 2020 looking for studies including outcomes from …
Authors
Bell C; Tandon P; Lentz E; Marshall JK; Narula N
Journal
Journal of Gastroenterology and Hepatology, Vol. 36, No. 10, pp. 2640–2648
Publisher
Wiley
Publication Date
October 2021
DOI
10.1111/jgh.15574
ISSN
0815-9319